logo
Plastic Bag Bans And Fees Can Reduce Shoreline Litter, Study Finds

Plastic Bag Bans And Fees Can Reduce Shoreline Litter, Study Finds

Forbes19 hours ago

EGYPT, RED SEA - DECEMBER 2007: Overview of plastic pollution during a dive on December 6, 2007, off ... More Egypt, Red Sea. In 2050, there will be more plastic than fish in the oceans if nothing is done, its the WWF (World Wildlife Fund). Plastics pollution has a direct and deadly effect on wildlife. Thousands of seabirds and sea turtles, seals and other marine mammals are killed each year. (Photo by)
Plastic bag bans and fees could help reduce the number ending up littering shorelines by at least a quarter, according to a new analysis.
The study by researchers at the University of Delaware and Columbia University found that plastic bag policies led to a 25% to 47% decrease in plastic bags as a share of total items collected in shoreline cleanups, compared to areas without policies.
It also found a 30 to 37% reduction in presence of entangled animals in areas with plastic bag policies.
It used data collected by volunteers with Ocean Conservancy's International Coastal Cleanup annual event, which sees volunteers remove trash from beaches and waterways around the world.
The U.S. currently has now no federal plastic bag policy, but there are various policies at the town, county and state level, which include bans, partial bans and charges.
The study says some types of policies seemed to be more effective than others in reducing plastic litter.
For instance, it said fees appear to reduce litter even more than bans, though more study is needed to understand why.
Another finding was that the bag bans and fees were most effective in places where the plastic bag litter problem was more severe to begin with.
Report co-author Anna Papp said roughly one-third of Americans are living in an area with some sort of plastic bag policy in place in a statement.
Papp added the findings do show that plastic bag policies are broadly effective in limiting litter along shorelines.
'Ours is the first large-scale study to use hundreds of policies and tens of thousands of cleanups to look at their effects,' she said.
'But it is important to keep in mind that this is a relative decrease in affected areas compared to areas without policies.'
A previous analysis by Ocean Conservancy showed a 29% reduction in plastic grocery bags found on beaches following an increase in statewide plastic bag bans.
It also claimed Americans use 100 billion plastic grocery bags each year and on average, plastic grocery bags are used for only 12 minutes before being thrown away.
Ocean Conservancy's manager for ocean plastics research, Dr. Erin Murphy said plastic bags are particularly dangerous for the environment in an interview.
Dr. Murphy said sea animals can either become entangled with them or ingest them.
She added the ingestion of plastic bags has been linked to death in many species, including marine mammals and sea turtles.
'Plastic bags can look to some sea creatures like prey such as jellyfish, and so they may be consumed preferentially in the environment,' she told me.
Dr. Murphy said there have also been previous studies, which highlight how high levels of plastic litter can impact tourism in coastal resorts.
She added the study provides good evidence about why 'more comprehensive plastic bag bans or well-developed plastic bag fees' need to be introduced.
The Ellen MacArthur Foundation's lead of strategy and thought leadership for the plastics initiative, Sander Defruyt said the new research provides clear evidence that plastic bag bans and fees are effective tools in reducing plastic pollution in an email.
Defruyt added plastic bags represent just a fraction of all plastics used globally and tackling the plastic pollution crisis requires a much broader systems change.
'We must change how we design, use, and reuse plastics. We cannot simply recycle or reduce our way out of the plastic pollution crisis,' he said.
'Our current wasteful linear plastics economy is broken," added Defruyt.
"In this system, fossil resources are extracted from the ground, made into packaging or products, and most often discarded after a very short, single use to end up in landfills, incinerators, or worse, into the environment.
'To fundamentally transform today's linear economy into a circular economy will require a combination of ambitious industry action and policy measures, working in tandem to provide the systems change required," said Defruyt.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Spider With No Venom Has a Deadly Trick to Poison Its Prey
Spider With No Venom Has a Deadly Trick to Poison Its Prey

Yahoo

time7 hours ago

  • Yahoo

Spider With No Venom Has a Deadly Trick to Poison Its Prey

In an unexpected twist, a non-venomous spider has been caught poisoning its victims by lacing its silk wrappings with vomited toxins. The feather-legged lace weaver (Uloborus plumipes), common across Europe and Africa, lacks venom glands on its head, so it was thought to be harmless. But biologists suspected this arachnid uses a different method of chemical warfare. University of Lausanne ecologist Xiaojing Peng and colleagues have now discovered that lace weavers regurgitate toxins from their midgut onto their silk-wrapped prey to subdue them. While the gut-toxin compounds are different from those found in the fangs of venomous spiders, they appear to be just as effective at disabling prey. Related: "These samples proved highly insecticidal, killing an average of 50 percent of fruit flies within an hour of inoculation," says ecologist Giulia Zancolli, also from the University of Lausanne. The researchers found these toxic proteins were similar to those in the digestive fluids of other spiders, like Parasteatoda tepidariorum, despite this species having venom glands as well. "These findings demonstrate that spider toxins are not exclusively confined to specialized venom-secreting glands but also play a role in the digestive system," explain Peng and team in their paper. "This supports an evolutionary link between the two systems, suggesting that toxins may have initially served digestive functions before being co-opted for venom use." Unlike their venomous counterparts, U. plumipes lack ducts in their fangs for injecting anything, the researchers confirmed. They suspect the lace weaver lost its venom over time, but then compensated by shifting to using its digestive toxins. While spiders are often feared for their venomous ways, they play a crucial role in our ecosystems, keeping insect numbers at bay while providing food for many birds, reptiles, and other animals, even humans, some while looking quite spectacular, too. Their venoms have also shown promise for potential medical uses, so it might be worth investigating the properties of their gut toxins as well. This research has been published in BMC Biology. Dolphins Got Giant Testicles. We Got a Chin. Only One Makes Sense. 4-Billion-Year-Old Stripey Rocks in Canada May Be The Oldest on Earth Scientific First: Mice With Two Fathers Now Have Offspring

A new AI breakthrough helped one couple get pregnant after 19 years—here's what it could mean for others
A new AI breakthrough helped one couple get pregnant after 19 years—here's what it could mean for others

Yahoo

time13 hours ago

  • Yahoo

A new AI breakthrough helped one couple get pregnant after 19 years—here's what it could mean for others

For nearly 19 years, Rosie and her husband tried to grow their family. Their journey spanned 15 IVF cycles, countless doctor visits, and emotional highs and lows that left them exhausted but still hopeful. Each attempt came with the quiet ache of disappointment. Still, they held onto their dream. In March 2025, something changed. Doctors at Columbia University Fertility Center helped the couple achieve what had always felt just out of reach—a successful pregnancy. What made the difference wasn't a new medication or procedure, but a scientific advance that sounded almost improbable: artificial intelligence. A novel AI-powered tool, developed by a team led by Dr. Zev Williams, found what doctors had never been able to detect in her husband's semen sample—viable sperm. That discovery led to the first pregnancy in the world using this new technology. Fertility care has long focused on women, despite male factors contributing to nearly 40% of infertility cases. Azoospermia—a condition where no sperm are found in the ejaculate—is among the most challenging to treat. Even with advanced microscopes, sperm can be nearly impossible to detect, and options are often limited to surgery or donor sperm. For many couples, especially those with religious or cultural reasons to avoid donor conception, that leaves few alternatives. This gap in care reflects deeper assumptions in reproductive medicine, where male fertility is often underexamined. The system, called STAR, is designed specifically to help address cases of azoospermia in a noninvasive and sperm-preserving way—offering a long-overdue shift in how male infertility is approached. Related: The Truth about Men's Infertility To tackle azoospermia, researchers at Columbia University developed a system called STAR (Sperm Track and Recovery). It uses artificial intelligence and a microfluidic chip to scan millions of microscopic images, identifying and isolating rare sperm that would otherwise go unnoticed. If sperm are detected, the system isolates and collects them—gently enough for use in IVF. In tests, STAR found dozens of sperm in samples that human embryologists had spent days analyzing without success. The inspiration came from astronomy, where AI helps spot new stars in a sky full of noise. Here, the system scans semen samples with similar precision. When STAR detects sperm, it diverts that tiny portion for collection—preserving viable cells for fertilization. In one early test, embryologists spent two days combing through a sample without success. STAR found 44 sperm in under an hour. It's opening doors for couples who were once told they had no options—offering more than just speed. This marks the first reported case where AI has been used not only to detect sperm in complex samples, but also to physically recover them for use in fertility treatment—offering new hope to families who previously had few or no options. Related: It's time to stop calling infertility a women's health issue For nearly two decades, Rosie and her husband dreamed of starting a family. After 15 unsuccessful IVF cycles and years of searching for answers, they were told that her husband's azoospermia left them with few options beyond using donor sperm—something they weren't ready to accept. Then they heard about STAR. Through a community group, Rosie connected with Dr. Zev Williams' team and learned about the new AI technology. For the first time, there was a tool that could potentially find viable sperm in a noninvasive, chemical-free way. That was enough to give them the courage to try one more cycle. This time, STAR found sperm—enough to fertilize Rosie's eggs. Just days later, she got the call she never thought she'd receive: she was pregnant. Now four months along, she says she still wakes up in disbelief. But the scans are real—and so is her baby. Related: The powerful documentary 'One More Shot' captures infertility on film like never before The success of STAR marks a technological milestone and signals a new frontier in understanding and treating infertility. Traditionally, couples facing azoospermia had few options beyond donor sperm. Now, STAR offers a potential path forward by making it possible to locate and retrieve even extremely rare sperm without damaging them. Here's what STAR could mean for the future of fertility care: Faster, more precise sperm selection: STAR scans millions of frames per hour, identifying and isolating viable sperm in real time. Expanded options for couples facing male-factor infertility: The technology may help those who were previously told they had no viable options. Less reliance on invasive or costly procedures: By improving sperm detection, STAR could reduce the need for more aggressive interventions. A shift in how infertility is approached clinically: STAR's success could signal a broader rethinking of diagnostic and treatment pathways. Potential to democratize access to advanced fertility care: As the technology becomes more scalable, it may increase availability and affordability. As Dr. Zev Williams explains, this AI doesn't replace the human touch; it extends it. With STAR, the goal is to give couples facing daunting odds a better chance—something that's long felt out of reach. AI is quietly transforming the way fertility challenges are understood and treated. Tools like STAR aren't science fiction—they're already helping families who've spent years navigating heartbreak and uncertainty. By spotting what even the most skilled eyes can miss, AI is opening new doors in cases that once seemed hopeless. For parents and parents-to-be, this isn't just about technology—it's about renewed possibility. As research continues, innovations like STAR could offer more families the chance to grow, with less guesswork and more hope.

Foldax Announces Positive One-Year Data on TRIA Mitral Valve
Foldax Announces Positive One-Year Data on TRIA Mitral Valve

Business Wire

time17 hours ago

  • Business Wire

Foldax Announces Positive One-Year Data on TRIA Mitral Valve

SALT LAKE CITY--(BUSINESS WIRE)--Foldax® Inc., a leader in the development of innovative polymer heart valves, today announced compelling one-year results from the India Clinical Trial of the TRIA™ Mitral Valve, showing a good safety profile, sustained hemodynamic performance, and statistically significant improvement in patient quality of life. These are the first one-year outcomes ever presented for a multicenter clinical study of a polymer heart valve worldwide. Results were presented today at New York Valves 2025, the annual conference organized by the Cardiovascular Research Foundation (CRF), and concurrently published in the Journal of the American College of Cardiology (JACC). 'It is exciting to see the positive clinical outcomes associated with this novel polymer valve.' Isaac George, M.D., Surgical Director of the Heart Valve Center at Columbia University. Share Key one-year results from the trial showed: No valve-related mortality or reinterventions >50% reduction in mean gradient (9.7 mmHg to 4.5 mmHg) and >90% increase in effective orifice area (0.9 cm² to 1.5 cm²), the highest reported in similar surgical mitral valve studies 24-point improvement in KCCQ score (57.5 to 81.9) and 65% increase in Six-Minute Walk Test distance (298.1 m to 494.8 m), indicating significant improvement in quality of life The prospective, multicenter trial enrolled 67 patients aged 19 to 67 across eight sites in India, with an average age of 42. Notably, 64% were women, and of these, nearly half were of childbearing age, a significantly larger percentage than typically seen in clinical studies. Seventy-three percent of patients had rheumatic heart disease. 'It is exciting to see the positive clinical outcomes associated with this novel polymer valve,' said Isaac George, M.D., Surgical Director of the Heart Valve Center at Columbia University. 'This new type of valve sets out to reimagine how a device can address clinical needs that are underserved by current valve solutions.' 'I am proud to be the principal investigator in India for this groundbreaking trial and represent the highly esteemed clinical investigators who participated in the study,' said Kaushal Pandey, M.D., Principal Investigator of the TRIA Mitral Valve India Clinical Trial and Cardiac Surgeon at P.D. Hinduja Hospital in Mumbai. 'The TRIA Mitral Valve provides hope for Indian patients—including younger patients and many women of childbearing age—for whom current valve options often fall short.' Foldax's vision for its novel polymer heart valves is to address the limitations of tissue and mechanical options by making its valves durable, with the future goal of avoiding a requirement for lifelong anticoagulation. TRIA valves incorporate a proprietary polymer—LifePolymer™ —formulated to be calcium-resistant, biostable and biocompatible. The novel polymer material enables TRIA valves to be robotically produced, which is designed to increase manufacturing efficiency and maximize product quality and precision. 'These results validate our strategy of taking heart valve therapy to a new level by bringing innovation to a platform of products that will help patients globally,' said Ken Charhut, CEO of Foldax. The Journal of the American College of Cardiology (JACC) publication can be viewed at: *The TRIA Mitral Valve is approved for use in India by CDSCO. The TRIA Mitral Valve is for investigational use only and is not available for commercial sale in the U.S. Headquartered in Salt Lake City, Utah, Foldax is reinventing every aspect of the heart valve—from material to design to manufacturing—to develop surgical and transcatheter valves with the potential to last a lifetime, addressing limitations of tissue and mechanical valves. Foldax investors include Angel Physicians Fund, Biostar Capital, Caltech, Glenview Capital, Kairos Ventures, Memorial Care Innovation Fund and Sayan Bioventures. For more information on the TRIA Mitral Valve and Foldax's commitment to revolutionizing heart valve care, visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store